Jiangsu To Invest CNY400mn In New Production Facility
News: China-based Jiangsu Nhwa Pharmaceutical is planning to invest CNY400mn (US$64.99mn) to build a chemical drug production facility in Xuzhou, China. The company also plans to use the new production facility as an export base for raw pharmaceutical materials. Of the total CNY400mn (US$64.99mn), the company plans to invest CNY370mn (US$60.11mn) in the construction of the plant, including investment in fixed assets. The construction of the plant is expected to be completed in 18 months.